Jørgen Drejer

Jørgen Drejer was the founder of NTG Nordic Transport Group A, founded in 1989, where the title held was Executive Vice President & Director-Drug Discovery.
Dr. Drejer was the founder of NsGene A, founded in 1999, with the title of Director from 1999 to 2012.
Dr. Drejer is the founder of Saniona AB, founded in 2011, holding the title of Deputy Chairman starting in 2025.
Dr. Drejer is also the founder of Sophion Bioscience A,Aniona ApS..
Dr. Drejer currently holds the position of Director at 2cureX ApS since 2017.
Dr. Drejer is Director at the Danish National Research Foundation.
Dr. Drejer is Director at the Danish Council for Independent Research.
Dr. Drejer is Director at Saniona A. Dr. Drejer is Independent Director at Qlife Holding AB starting in 2025.
Dr. Drejer is Directorb at Cephagenix ApS.
Dr. Drejer is a Member of The Danish Academy of Technical Sciences.
Former positions include Co-Chairman at Delta Reader A, Director at MediCult A, Director at FORCE Technology, Director at Azign Bioscience AS, Director at Atonomics A from 2005 to 2015, Director at Bok Holding A, Director at DELTA A from 2008 to 2016, Director at Origio A from 1998 to 2012, Director at Poseidon Pharmaceuticals A, Director at Aktieselskabet af 20.
November 2003, Director at Ellegaard Göttingen Minipigs A, Director at MonTa Biosciences ApS, Independent Director at 2cureX AB, Director at DELTA, Dansk, Elektronik, Lys & Akustik, and Project Manager at Ferrosan ApS.
Education includes a doctorate from the University of Copenhagen.